Correction of Remaining Convertible Bond Issuance Limit to 344.8 Billion Won (from 341.8 Billion)
- Abpro Bio corrects remaining convertible bond issuance limit from 341.8 billion won to 344.8 billion won
- The correction is due to an error in the previously filed decision to issue convertible bonds on March 16, 2026
- The bonds include put options with early redemption rates increasing from 103.00% to 108.49% over eight periods starting from April 30, 2027
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)
- Company: Abpro Bio (195990)
- Submission: Abpro Bio Co., Ltd.
- Receipt: 04-28-2026
- Amended (Refer to related filing)